GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,192,000 | +58.7% | 115,638 | -3.1% | 3.74% | +46.2% |
| Q3 2019 | $5,792,000 | -3.9% | 119,372 | +4.2% | 2.56% | +7.9% |
| Q2 2019 | $6,026,000 | -5.6% | 114,562 | -5.0% | 2.37% | +8.3% |
| Q1 2019 | $6,383,000 | +102.2% | 120,594 | +56.8% | 2.19% | +120.5% |
| Q4 2018 | $3,157,000 | -1.8% | 76,899 | -9.1% | 0.99% | +10.2% |
| Q3 2018 | $3,214,000 | -40.1% | 84,579 | -28.8% | 0.90% | -49.3% |
| Q2 2018 | $5,369,000 | +116.2% | 118,775 | +131.0% | 1.78% | +45.9% |
| Q1 2018 | $2,483,000 | +23.0% | 51,412 | +0.2% | 1.22% | +40.3% |
| Q4 2017 | $2,019,000 | – | 51,301 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
| Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
| Grace Capital | 98,939 | $13,970,000 | 5.34% |
| GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
| Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
| Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
| Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
| NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
| Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |